Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis

Medical Science Monitor

Volumn 9, Issue 5, 2003, Pages

  Kurkowska Jastrzȩbska, Iwona ^a   Wicha, Wojciech ^a   Dowzenko, Anatol ^b   Vertun Baranowska, Barbara ^c   Pytlewski, Andrzej ^a   Bogusławska, Romana ^a   Członkowska, Anna ^a,d  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b CENTRAL CLINICAL HOSPITAL OF THE MINISTRY OF INTERIOR   (Poland)

^c INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^d 2nd Department of Neurology   (Poland)

Author keywords

Anticoagulant treatment; Factor V Leiden; Prothrombin; Risk factors; Venous stroke

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ADULT; APHASIA; ARTICLE; CASE REPORT; CAUCASIAN; CEREBRAL SINUS THROMBOSIS; CEREBRAL VENOUS THROMBOSIS; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC RISK; GENETIC VARIABILITY; GRAND MAL SEIZURE; HEADACHE; HEMIPLEGIA; HOMOZYGOSITY; HUMAN; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEIC ACID BASE SUBSTITUTION; PROTHROMBIN GENE; RISK FACTOR; STROKE; THROMBOSIS; VEIN THROMBOSIS; VOMITING;

ADULT; CEREBRAL VEINS; FACTOR V; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INTRACRANIAL THROMBOSIS; MUTATION; POINT MUTATION; PROTHROMBIN; RISK FACTORS; VARIATION (GENETICS);

EID: 0037832785     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. De Moerloose P, Reber G, Perrier A et al: Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thrombosis and metabolism. Br J Haematol, 2000; 110: 125-129
2. Poort SR, Rosendaal FR, Reitsma PR, Bertina RM: A common genetic variant in the 3′-untranslated regioa of the prothrombin gene is associated with elevated plasma prothrmbin levels and an increase in venous thrombosis. Blood, 1996; 88: 3698-3703
3. Corral J, Zuazu-Jausoro I, Rivera J et al: Clinical and analytical relevance of the combination of prothrombin 20210A/A and factor V Leiden: results from a large family. Br J Haematol, 1999; 105: 560-563
4. Bertina RM, Koeleman BPC, Koster T et al: Mutation in blood coagulation factor V associated with resostance to activated protein C. Nature, 1994; 369: 64-67
5. Bridey F, Wolff M, Laissy JP et al: Fatal cerebral venous sinus thrombosis associated with the factor V Leiden mutation and the use of oral contraceptives. Thromb Haemost, 1995; 74: 1382
6. Emmerich J, Rosendaal FR, Cattaneo M et al: Combined effect of factor V Leiden and prothrombin 20210 A on the risk of venou thromboembolism-pooled analysis of 8 case-control studies including 2310 cases and 3404 controls. Study Group for Pooled Analysis of Venous Thromboembolism. Thromb Haemost, 2001; 86: 809-816
7. Longstreth WT, Rosendaal FR, Siscovick DS et al: Risk of stroke in young women and two prothombotic mutation: factor V Leiden and prothrombin gene variant G20210A. Stroke, 1998; 29: 577-580
8. Weinstein JR, Gold SJ, Cunningham DD, Gall CM: Cellular localisation of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J Neurosci, 1995; 15: 2906-19
9. Rosendaal FR, Duggen CJ, Zivelin A et al: Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost, 1998; 79: 706-708
10. Ahsen N, Lewczuk P, Schutz E et al: Prothrombin activity and concentration in healthy subjects with and without prothrombin G20210A mutation. Thrombosis Res, 2000; 99: 549-556
11. Kyrle PA, Mannhalter C, Begnin S et al: Clinical studies and thrombin generation in patients homozygous and heterozygous for the G20210A mutation in the prothrombin gene. Arterioscler Thromb Vasc Biol, 1998; 18: 1287-91
12. De Stefano V, Martinelli I, Mannucci PM et al: The risk of reccurent deep venous thrombosis among heterozygous carriers of both factor Leiden and the G20210A prothrombin mutation. N engl J Med, 1999; 341: 804-806
13. Rosendaal FR, Siscovick DS, Schwartz SM, et al: A common prothrombin variant (20210 GtoA) increases the risk of myocardial infarction in young women. Blood, 1997; 90: 1747-1750
14. De Bruijn SF, Stam J, Koopman MM, Vandenbroucke JP: Case control study of risk of cerebral sinus thrombosis in oral contraceptives users and in carriers of hereditary prothrombotic conditions. BMJ, 1998; 16: 822
15. Rosendaal FR, Vessey, Rumley A et al: Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis. Br J Haematol, 2002; 116: 851-854
16. van Boven HH, Vandenbroucke JP, Briet E, Rosendaal FR: Genegene and gene-envirenment interactions determine risk of thrombosis in families with inherited antithrombin deficiency. Blood, 1999; 94: 2590-2594
17. Bykowska K, Vertun-Baranowska B, Windyga J, Lopaciuk S: Prevalence of G20210A prothrombin gene mutation in Poland. Pol Arch Med Wewn, 2000; 104: 729-733
18. Huisman MV, Rosendaal F: Thrombophilia. Curr Opin Hematol, 1999; 6: 291-297
19. Preter M, Tzourio C, Ameri A, Bousser MG: Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients. Stroke, 1996, 27: 243-246
20. Kalbag RM, Woolf AL: Cerebral venous thrombosis. London: Oxford University Press, 1967
21. Bousser M, Chiras J, Castaigne P: Cerebral venous thrombosis: a review of 38 cases. Stroke, 1985; 16: 199-213
22. Einhaupl KM, Villringer A, Meister W et al: Heparin treatment in sinous venous thrombosis. Lancet, 1991; 338: 597-600
23. De Bruijn SF, Stam J: Randomized, placebo controlled trial ofanticoagulant treatment with low-molecular weight heparin for cerebral sinus thrombosis. Stroke, 1999; 30: 484-488
24. Stam J, De Bruijn SF, De Veber G: Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev 2002; 4: CD002005
25. Yamini B, Macdonald RL, Rosenblum J: Treetment of deep cerebral venous thrombosis by local infusion of tissue plasminogen activator. Surg Neurol, 2001; 55: 340-346
26. de Bruijn SF, Budde M, Teunisse S et al: Long-term outcome of cognition and functional health after cerebral venous sinus thrombosis. Neurology, 2000; 54: 1687-1689